ADJUVANT

Clinical trials for ADJUVANT explained in plain language.

Never miss a new study

Get alerted when new ADJUVANT trials appear

Sign up with your email to follow new studies for ADJUVANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

New pill aims to keep early lung cancer from coming back after surgery

Disease control Ongoing

This study tests whether adding the drug zipalertinib to standard chemotherapy after lung cancer surgery helps prevent the cancer from returning. It is for people with early-stage (IB-IIIA) non-small cell lung cancer that has specific uncommon EGFR mutations. About 360 participan…

Matched conditions: ADJUVANT

Phase: PHASE3 • Sponsor: Taiho Oncology, Inc. • Aim: Disease control

Last updated May 15, 2026 11:56 UTC

ADJUVANT

Get alerted when new ADJUVANT trials appear

New pill aims to keep early lung cancer from coming back after surgery